Newborn Screening Equity in Spain: Progress and Persistent Gaps

Newborn screening (NBS) in Spain has evolved from regionally developed programmes towards an increasingly harmonised national framework. However, differences in screening panels, implementation, and programme performance persist within its decentralised health system. This study examines the evolution of Spanish NBS and the implications of territorial variation, programme performance, and recent policy developments for equity. I conducted a descriptive documentary analysis of historical and scientific publications, national legislation, Ministry of Health programme evaluations for 2016–2024, official regional information, and selected patient-organization and stakeholder materials. A condition-by-territory dataset was compiled for the 17 autonomous communities and the autonomous cities of Ceuta and Melilla, comprising 83 condition entries classified according to their documented screening status. The territorial compilation identified 22–48 primary condition entries per territory, with additional heterogeneity in the classification of secondary findings. In 2024, NBS participation exceeded 99.5%; sample-collection timing met the national acceptable or optimal criteria in 16/19 territories and transport timing in 9/19, while individual follow-up information covered approximately 55% of confirmed cases. The common national portfolio expanded to 21 conditions in 2026, accompanied by a new framework for periodic evaluation and updating. The documentary analysis also identified increasing societal mobilisation around NBS, bringing territorial differences and delayed diagnosis into the wider public and policy debate. Regional innovation and emerging genomic approaches add further dimensions to the relationship between innovation and equity. Spain has made substantial progress towards a more harmonised NBS system, but equity cannot be assessed by panel composition alone. It requires comparable implementation, timely confirmation and treatment, robust follow-up and sustainable clinical pathways. Future governance should combine national harmonisation with opportunities for evidence-generating regional innovation, transparent evaluation and meaningful societal participation. These principles will become increasingly important as NBS expands and genomic screening moves closer to clinical implementation.

Authors

Institutions

Publication Details

Journal
International Journal of Neonatal Screening
Published
2026-11-18
DOI
https://doi.org/10.3390/ijns12040103
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Newborn Screening Equity in Spain: Progress and Persistent Gaps

Raquel Yahyaoui
2 links
International Journal of Neonatal Screening
Metabolism and Genetic Disorders
article

Newborn Screening Equity in Spain: Progress and Persistent Gaps

Raquel Yahyaoui
article en

Abstract

Newborn screening (NBS) in Spain has evolved from regionally developed programmes towards an increasingly harmonised national framework. However, differences in screening panels, implementation, and programme performance persist within its decentralised health system. This study examines the evolution of Spanish NBS and the implications of territorial variation, programme performance, and recent policy developments for equity. I conducted a descriptive documentary analysis of historical and scientific publications, national legislation, Ministry of Health programme evaluations for 2016–2024, official regional information, and selected patient-organization and stakeholder materials. A condition-by-territory dataset was compiled for the 17 autonomous communities and the autonomous cities of Ceuta and Melilla, comprising 83 condition entries classified according to their documented screening status. The territorial compilation identified 22–48 primary condition entries per territory, with additional heterogeneity in the classification of secondary findings. In 2024, NBS participation exceeded 99.5%; sample-collection timing met the national acceptable or optimal criteria in 16/19 territories and transport timing in 9/19, while individual follow-up information covered approximately 55% of confirmed cases. The common national portfolio expanded to 21 conditions in 2026, accompanied by a new framework for periodic evaluation and updating. The documentary analysis also identified increasing societal mobilisation around NBS, bringing territorial differences and delayed diagnosis into the wider public and policy debate. Regional innovation and emerging genomic approaches add further dimensions to the relationship between innovation and equity. Spain has made substantial progress towards a more harmonised NBS system, but equity cannot be assessed by panel composition alone. It requires comparable implementation, timely confirmation and treatment, robust follow-up and sustainable clinical pathways. Future governance should combine national harmonisation with opportunities for evidence-generating regional innovation, transparent evaluation and meaningful societal participation. These principles will become increasingly important as NBS expands and genomic screening moves closer to clinical implementation.

International Journal of Neonatal ScreeningVol. 12(4)
Hospital Regional Universitario de Málaga (ES), Andalusian Centre for Nanomedicine and Biotechnology (ES), Instituto de Investigación Biomédica de Málaga (ES), Universidad Europea de Andalucía (ES)
Good health and well-being, Reduced inequalities
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon